MATTERN PHARMA AG

City:

Vaduz

Country:

Liechtenstein

Published Applications:

Last publication date:

2017-07-06

Patent Grants:

Last grant date:

2018-05-08

Top Inventors for applications by MATTERN PHARMA AG

These are the the leading inventors for applications assigned to MATTERN PHARMA AG:

Claudia MATTERN 5 Stans, Switzerland
Claudia Mattern 4 Emmetten, Switzerland

Recent patent applications by MATTERN PHARMA AG

MATTERN PHARMA AG based in Vaduz, LI has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-07-06 ✅ Patent 9,962,394 granted on 2018-05-08

US20170189414A1

Human necessities

Controlled release delivery system for nasal applications and method of treatment

#2 | 2016-05-19 ✅ Patent 9,579,280 granted on 2017-02-28

US20160136090A1

Human necessities

Controlled release delivery system for nasal applications and method of treatment

#3 | 2016-03-31 ✅ Patent 9,801,834 granted on 2017-10-31

US20160089347A1

Human necessities

Controlled release delivery system for nasal application of neurotransmitters

#4 | 2015-01-01 ✅ Patent 9,238,072 granted on 2016-01-19

US20150005271A1

Human necessities

Controlled release delivery system for nasal applications and method of treatment

#5 | 2014-03-13 ✅ Patent 8,784,869 granted on 2014-07-22

US20140073618A9

Human necessities

CONTROLLED RELEASE DELIVERY SYSTEM FOR NASAL APPLICATIONS AND METHODS OF TREATMENT

#6 | 2012-11-01 ✅ Patent 8,784,869 granted on 2014-07-22

US20120277202A1

Human necessities

Controlled release delivery system for nasal applications and methods of treatment

#7 | 2012-04-05 ✅ Patent 8,877,230 granted on 2014-11-04

US20120083480A1

Human necessities

Controlled release delivery system for nasal applications

#8 | 2012-03-08 ✅ Patent 8,784,882 granted on 2014-07-22

US20120058176A1

Human necessities

Controlled release delivery system for nasal applications and method of treatment

#9 | 2012-01-12 ✅ Patent 9,186,320 granted on 2015-11-17

US20120009249A1

Human necessities

Controlled release delivery system for nasal application of neurotransmitters

Also check out MATTERN PHARMA AG's (Vaduz, Liechtenstein) applicant profile with 2 patent applications submitted.

AssigneeID:

85639 ⎘